Sammenlign metoder
Gjennomgå de valgte metodene side om side; rader som avviker, er uthevet.
| Eating Attitudes Test (EAT-26)× | Borderline Symptom List (BSL-95)× | |
|---|---|---|
| Fagfelt | Psykiatri | Psykiatri |
| Familie | Process / pipeline | Process / pipeline |
| Opprinnelsesår≠ | 1979 | 2007 |
| Opphavsperson≠ | David M. Garner | Martin Bohus |
| Type | Self-report questionnaire | Self-report questionnaire |
| Opprinnelig kilde≠ | Garner, D. M., Olmsted, M. P., Bohr, Y., & Garfinkel, P. E. (1982). The eating attitudes test: Psychometric features and clinical correlates. Psychological Medicine, 12(4), 871–878. DOI ↗ | Bohus, M., Kleindienst, N., Limberger, M. F., Stieglitz, R. D., Domsalla, M. E., Chapman, A. L., ... & Wolf, M. (2009). The short version of the Borderline Symptom List (BSL-23): Development and initial data on psychometric properties. Psychopathology, 42(1), 32–39. DOI ↗ |
| Alias≠ | EAT-26, EAT (original 40-item) | BSL, BSL-95, Borderline Symptom List-95 |
| Relaterte | 3 | 3 |
| Sammendrag≠ | The EAT-26 is a 26-item self-report questionnaire designed to assess core attitudes and behaviors characteristic of eating disorders, particularly anorexia nervosa and bulimia nervosa. Developed by Garner and Garfinkel in 1979 and abbreviated to 26 items in 1982, it is widely used for screening eating disorders in community and clinical settings, and for monitoring treatment response. The EAT-26 measures restrictive eating attitudes, food preoccupation, and weight/shape concerns, with three subscales reflecting the multifaceted nature of eating disorder psychopathology. | The BSL-95 is a 95-item self-report questionnaire designed to measure the severity of borderline personality disorder (BPD) symptoms across nine subscales: affect dysregulation, distrust, self-harming behaviors, suicide risk, identity disturbance, negative relationships, and dissociation. Developed by Bohus and colleagues in 2007, it provides comprehensive assessment of the multifaceted psychopathology of BPD. A brief 23-item version (BSL-23) has also been validated for rapid assessment. The BSL is sensitive to treatment effects and widely used in BPD research and clinical monitoring. |
| ScholarGateDatasett ↗ |
|
|